Comparative effectiveness research in oncology methodology: observational data
- PMID: 23071228
- DOI: 10.1200/JCO.2012.41.6701
Comparative effectiveness research in oncology methodology: observational data
Abstract
The goal of comparative effectiveness research is to inform clinical decisions between alternate treatment strategies using data that reflect real patient populations and real-world clinical scenarios for the purpose of improving patient outcomes. Observational studies using population-based registry data are increasingly relied on to fill the information gaps created by lack of evidence from randomized controlled trials. Administrative data sets have many advantages, including large sample sizes, long-term follow-up, and inclusion of data on physician and systems characteristics as well as cost. In this review, we describe the characteristics of many of the commonly used population-based data sets and discuss the elements included within these data sets. An overview of common research themes that rely on population-based data and illustrative examples are presented. Finally, an overview of the analytic techniques commonly employed by health services researchers to limit the effects of selection bias and confounding is discussed. The analysis of well-designed studies of comparative effectiveness is complex. However, careful framing, appropriate study design, and application of sophisticated analytic techniques can improve the accuracy of nonrandomized studies. There are multiple areas where the unique characteristics of observational studies can inform medical decision making and health policy, and it is critical to appreciate the opportunities, strengths, and limitations of observational research.
Similar articles
-
The role of observational investigations in comparative effectiveness research.Value Health. 2010 Dec;13(8):989-97. doi: 10.1111/j.1524-4733.2010.00786.x. Value Health. 2010. PMID: 21138497 Review.
-
The methods of comparative effectiveness research.Annu Rev Public Health. 2012 Apr;33:425-45. doi: 10.1146/annurev-publhealth-031811-124610. Epub 2012 Jan 3. Annu Rev Public Health. 2012. PMID: 22224891 Review.
-
Revisiting issues, drawbacks and opportunities with observational studies in comparative effectiveness research.J Eval Clin Pract. 2013 Aug;19(4):579-83. doi: 10.1111/j.1365-2753.2011.01802.x. Epub 2011 Nov 29. J Eval Clin Pract. 2013. PMID: 22128798
-
"Lies, damned lies ..." and observational studies in comparative effectiveness research.Am J Respir Crit Care Med. 2013 Jun 1;187(11):1173-7. doi: 10.1164/rccm.201212-2187OE. Am J Respir Crit Care Med. 2013. PMID: 23725614 Review.
-
An overview of methods for comparative effectiveness research.Semin Radiat Oncol. 2014 Jan;24(1):5-13. doi: 10.1016/j.semradonc.2013.09.002. Semin Radiat Oncol. 2014. PMID: 24314337 Review.
Cited by
-
Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?Curr Treat Options Oncol. 2024 Apr;25(4):405-426. doi: 10.1007/s11864-024-01186-4. Epub 2024 Feb 17. Curr Treat Options Oncol. 2024. PMID: 38367182 Free PMC article. Review.
-
Determinants of health-related quality-of-life in adult survivors of childhood cancer: integrating personal and societal values through a health utility approach.EClinicalMedicine. 2023 Apr 3;58:101921. doi: 10.1016/j.eclinm.2023.101921. eCollection 2023 Apr. EClinicalMedicine. 2023. PMID: 37090443 Free PMC article.
-
Breast cancer: emerging principles of metastasis, adjuvant and neoadjuvant treatment from cancer registry data.J Cancer Res Clin Oncol. 2023 Feb;149(2):721-735. doi: 10.1007/s00432-022-04369-4. Epub 2022 Dec 20. J Cancer Res Clin Oncol. 2023. PMID: 36538148 Free PMC article. Review.
-
Pediatric Cancer Registry at MAHAK Pediatric Cancer Treatment and Research Center: A Single-Center Study from Iran.Int J Hematol Oncol Stem Cell Res. 2022 Apr 1;16(2):86-93. doi: 10.18502/ijhoscr.v16i2.9201. Int J Hematol Oncol Stem Cell Res. 2022. PMID: 36304728 Free PMC article.
-
Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system.J Gynecol Oncol. 2022 May;33(3):e26. doi: 10.3802/jgo.2022.33.e26. Epub 2022 Feb 3. J Gynecol Oncol. 2022. PMID: 35320882 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
